Home > Income Statement > INDOCO REMEDIES

INDOCO REMEDIES
Consolidated Net Profit

    Back to Income Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹-74 Cr₹98 Cr₹142 Cr₹155 Cr₹93 Cr

What is the latest Consolidated Net Profit of INDOCO REMEDIES ?

The latest Consolidated Net Profit ratio of INDOCO REMEDIES is ₹-74 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹-74 Cr
Mar2024₹98 Cr
Mar2023₹142 Cr
Mar2022₹155 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of INDOCO REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹-74 Cr
Negative
Mar2024 ₹98 Cr
-30.78
Mar2023 ₹142 Cr
-8.11
Mar2022 ₹155 Cr
66.37
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,865.8 Cr 6.4% 4.2% -21.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

6.4%

4.2%

-21.7%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses